Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...

Reports Q4 revenue $47.1M vs. $38.6M last year. A significant amount of the increase is attributable to the base rate increase in the Middlesex ...

Reports Q4 revenue $1.7B, consenus $1.94B. “As we advance toward the anticipated close of the acquisition by Boeing in mid-2025, we continue to ...

Progyny (PGNY -1.68%), a pioneer in fertility benefits management, released its earnings for the fourth quarter on Feb. 27.

Okta (OKTA) is scheduled to report its fourth quarter earnings result on Monday, March 3rd, after the closing bell. Wall ...

Owens & Minor beat Q4 EPS and revenue estimates, announced a $100M buyback, and provided 2025 guidance, projecting ...

Q4 2025 Earnings Call Transcript February 28, 2025 Operator: Good afternoon and welcome to the Fiscal Year 2025 Fourth Quarter Financial Results Conference Call for Dell Technologies Inc. I’d like to ...

NovoCure remains a strong buy with robust earnings, growth in cancer treatments, and significant upside potential to Wall ...

NWN earnings call for the period ending December 31, 2024. Northwest Natural ( NWN -0.63%) Q4 2024 Earnings Call Feb 28, 2025 ...

Market heavyweight Nvidia (NVDA) delivered blockbuster results in Q4 of its fiscal year ended January 2025, which saw revenue ...

Recursion Pharmaceuticals (RXRX) delivered earnings and revenue surprises of -47.22% and 84.18%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...